COVID-19

Cipla prices COVID drug Favipiravir at Rs 68 per tablet; RIL breaks more records

Mukesh Ambani-led Reliance Industries Ltd (RIL) recorded the highest value of transactions for a share ever on NSE yesterday; The legal profession, like many other sectors, will see disruptive change with 20 per cent of the routine legal works likely to be automated in the future, predicts a survey conducted by BML Munjal University (BMU); Cipla on Friday said that it has received the Drug Controller General of India (DCGI) approval for the launch of experimental coronavirus drug Favipiravir in India for treatment of COVID-19 patients. Watch this and more on News Blast.

———————-
About the Channel: Watch Business Today videos to get the latest news on Business, stock market, sensex – BSE India, NSE India, personal finance, gold prices, petrol prices and more. Also, get an insight into the dealings of the top companies in India from Business Today’s award-winning journalists. Get up to date with all investment options (Mutual Funds, SIPs, Debt, Equity, Insurance, Home Loans, Pension Schemes, Retirement Plans) from our Money Today team. Also, watch interviews of top CEOs.
Regular shows to watch out:

The Good The Bad and The Ugly with BusinessToday.in Editor Rajeev Dubey to know the top stories of the day specially curated from the world of business and economy.

Watch Inside India’s Factories to find out how different products get manufactured and processed for final consumption.

You can follow us at:

Website:
Facebook:
Twitter:
Google Plus: